Saxenda (liraglutide) tracker
Educational reference for Saxenda (liraglutide). Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
13 h
Tmax
11 h
Category
glp1
> PLACEHOLDER — pending clinical review by licensed pharmacist. Saxenda is Novo Nordisk's brand of liraglutide for weight management.
Mechanism
Saxenda is a brand name for liraglutide, a GLP-1 receptor agonist, at the dose used for weight management. See the liraglutide entry for the full mechanism.
Research summary
Saxenda is the liraglutide product approved for chronic weight management (SCALE program). See the liraglutide entry for broader context.
Dosing in the literature
Regimens are individualized and set by a prescribing clinician; they are outside the scope of this summary. See the liraglutide entry.
Reported side effects
As a liraglutide product, gastrointestinal effects are most commonly reported; prescribing information includes class warnings. See the liraglutide entry. This is not a complete safety profile.
Stacking notes
See the liraglutide entry. Combination with other agents is a clinical decision.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Saxenda prescribing information / SCALE program · FDA prescribing information (2014)available via DailyMed; see liraglutide entry
References
Track Saxenda (liraglutide) in TrackPep
Reconstitution calculator, interactive body-map rotation, side-effect timeline, weight trends, and a private log — all in one place. Free to try.